Is Spruce Biosciences, Inc. (SPRB) a Buy, Sell, or Hold?
NASDAQ : SPRB
Spruce Biosciences, Inc. — Insider Trades
$47.07 USD
$0.66 (1.42%)
- Volume
- 26.08K
- Average Volume
- 70.76K
- Market Capitalization
- $129.55M
- P/E Ratio
- -1.15
- Dividend Yield
- 0.00%
- Price Target
- $140.00
- Year High
- $240.00
- Year Low
- $7.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.23
Insider Activity Summary (Last 12 Months)
Insiders Buying
51
Insiders Selling
46
Amount of Insider Selling
$52257
SPRB Insider Buying/Selling by Quarter
SPRB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Quartel Adrian W | officer: Chief Medical Officer | 2026-07-27 | A-Award | 0 | 2026-07-29 |
| Quartel Adrian W | 2026-07-27 | 0 | 2026-07-29 | ||
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2026-06-30 | A-Award | 4.5305 | 2026-07-09 |
| SPIEGELMAN DANIEL K | director | 2026-05-21 | A-Award | 52.7 | 2026-05-26 |
| SIMPSON CAMILLA V | director | 2026-05-21 | A-Award | 52.7 | 2026-05-26 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2026-05-21 | A-Award | 52.7 | 2026-05-26 |
| Barretto-Ko Percival | director | 2026-05-21 | A-Award | 52.7 | 2026-05-26 |
| Walbert Keli | director | 2026-05-21 | A-Award | 52.7 | 2026-05-26 |
| Hooks Corwin Dale | officer: Chief Commercial Officer | 2026-03-09 | A-Award | 0 | 2026-03-09 |
| Hooks Corwin Dale | 2026-03-09 | 0 | 2026-03-09 | ||
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | A-Award | 0 | 2026-01-21 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | M-Exempt | 0 | 2026-01-21 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | M-Exempt | 0 | 2026-01-21 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | A-Award | 104.13 | 2026-01-21 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | A-Award | 104.13 | 2026-01-21 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | D-Return | 791.25 | 2026-01-21 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | 2025-12-11 | D-Return | 169.5 | 2026-01-21 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-31 | A-Award | 4.5305 | 2026-01-05 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-15 | F-InKind | 80.67 | 2025-12-17 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-15 | F-InKind | 80.67 | 2025-12-17 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-15 | F-InKind | 80.67 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-15 | F-InKind | 80.67 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | A-Award | 104.13 | 2025-12-17 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-15 | M-Exempt | 0 | 2025-12-17 |
| SPIEGELMAN DANIEL K | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SPIEGELMAN DANIEL K | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SPIEGELMAN DANIEL K | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SPIEGELMAN DANIEL K | director | 2025-12-11 | D-Return | 1143 | 2025-12-15 |
| SPIEGELMAN DANIEL K | director | 2025-12-11 | D-Return | 169.5 | 2025-12-15 |
| SPIEGELMAN DANIEL K | director | 2025-12-11 | D-Return | 564 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | D-Return | 108 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | D-Return | 123 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | D-Return | 230.25 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | D-Return | 1143 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | D-Return | 186 | 2025-12-15 |
| GREY MICHAEL G | director, officer: Executive Chairman | 2025-12-11 | D-Return | 169.5 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | D-Return | 1506 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | D-Return | 123 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | D-Return | 344.25 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | D-Return | 186 | 2025-12-15 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | D-Return | 230.25 | 2025-12-15 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | D-Return | 344.25 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | D-Return | 230.25 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | D-Return | 169.5 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | D-Return | 1143 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | D-Return | 123 | 2025-12-15 |
| SIMPSON CAMILLA V | director | 2025-12-11 | D-Return | 108 | 2025-12-15 |
| Barretto-Ko Percival | director | 2025-12-11 | A-Award | 104.13 | 2025-12-15 |
| Barretto-Ko Percival | director | 2025-12-11 | D-Return | 169.5 | 2025-12-15 |
| Walbert Keli | director | 2025-12-11 | A-Award | 88.41 | 2025-12-15 |
| Walbert Keli | 2025-12-11 | 0 | 2025-12-15 | ||
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | M-Exempt | 0 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | F-InKind | 88.41 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | A-Award | 0 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-10 | M-Exempt | 0 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-10 | F-InKind | 85.67 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-11 | M-Exempt | 0 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-12-10 | M-Exempt | 0 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | A-Award | 0 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | M-Exempt | 0 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | M-Exempt | 0 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-11 | F-InKind | 88.41 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-10 | M-Exempt | 0 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-10 | F-InKind | 85.67 | 2025-12-12 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-10 | M-Exempt | 0 | 2025-12-12 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-10-20 | M-Exempt | 0 | 2025-10-22 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-10-20 | F-InKind | 148.16 | 2025-10-22 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-10-20 | A-Award | 0 | 2025-10-22 |
| Gharib Samir M. | officer: PRESIDENT AND CFO | 2025-10-20 | M-Exempt | 0 | 2025-10-22 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-10-20 | M-Exempt | 0 | 2025-10-22 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-10-20 | F-InKind | 148.16 | 2025-10-22 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-10-20 | A-Award | 0 | 2025-10-22 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-10-20 | M-Exempt | 0 | 2025-10-22 |
| Parkman Healthcare Partners LLC | 10 percent owner | 2025-10-06 | P-Purchase | 17.9108 | 2025-10-08 |
| Parkman Healthcare Partners LLC | 10 percent owner | 2025-10-06 | S-Sale | 19.3264 | 2025-10-08 |
| Parkman Healthcare Partners LLC | 10 percent owner | 2025-10-06 | S-Sale | 17.4557 | 2025-10-08 |